NCT05601817

Brief Summary

This research project is relevant to public health because both heart failure (HF) and mild cognitive impairment (e.g., trouble remembering and concentrating beyond normal aging) are highly prevalent among older adults in the United States. Despite advances in health care, there are no effective interventions for treating cognitive impairment in HF, which if left untreated, leads to suboptimal health, quality of life, and shorter survival. Therefore, the investigators propose to test the effect of a dual-component intervention comprised of a virtual reality-based cognitive restoration intervention and computerized cognitive training on cognitive function and overall health among 172 older adults with HF who experience mild cognitive impairment.

Trial Health

75
On Track

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
172

participants targeted

Target at P50-P75 for not_applicable heart-failure

Timeline
11mo left

Started Apr 2023

Longer than P75 for not_applicable heart-failure

Geographic Reach
1 country

1 active site

Status
active not recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Progress78%
Apr 2023Mar 2027

First Submitted

Initial submission to the registry

October 24, 2022

Completed
8 days until next milestone

First Posted

Study publicly available on registry

November 1, 2022

Completed
5 months until next milestone

Study Start

First participant enrolled

April 3, 2023

Completed
4 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 31, 2027

Expected
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 31, 2027

Last Updated

March 23, 2026

Status Verified

March 1, 2026

Enrollment Period

4 years

First QC Date

October 24, 2022

Last Update Submit

March 19, 2026

Conditions

Keywords

heart failuremild cognitive impairmentolder adultscognitive interventioncognitive trainingattention restorationvirtual reality

Outcome Measures

Primary Outcomes (2)

  • Changes in cognitive function: attention

    Trail Making and Number Span Test from National Alzheimer's Coordinating Center Neuropsychological battery (Uniform Data Set V3.0)

    Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline

  • Changes in cognitive function: memory

    Craft Story 21 and Benson Figure Copy for memory from National Alzheimer's Coordinating Center Neuropsychological battery (Uniform Data Set V3.0)

    Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline

Secondary Outcomes (5)

  • Changes in heart failure self-care

    Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline

  • Changes in instrumental activities of daily living

    Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline

  • Changes in instrumental activities of daily living

    Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline

  • Changes in health-related quality of life

    Baseline, 8 weeks, 16 weeks, and 1 year (52 weeks) after baseline

  • Dementia-free survival

    1 year after baseline

Study Arms (4)

Vita (virtual reality-based cognitive restoration intervention)

EXPERIMENTAL

Participants randomized to Vita will receive a virtual reality head-mount device (e.g., Oculus Quest) to view nature pictures for 10 minutes (1 set of 10 pictures)/day, 2-3 days/week for 8 weeks (a total of 20 sets for 200 minutes, approximately 3.3 hours) based on the provided activity schedule. Participants will receive weekly check-in calls from the intervention RA during the 8 weeks of intervention phase.

Behavioral: Vita

Com (computerized cognitive training intervention )

EXPERIMENTAL

Participants randomized to Com will receive a tablet computer (e.g., iPad) to complete BrainHQ training for 1 hour (6 exercises)/day, 2-3 days/week for 8 weeks (total of 20 hours) based on the provided activity schedule. Participants will receive weekly check-in calls from the intervention RA during the 8 weeks of intervention phase.

Behavioral: Com

Vita+Com (Both Vita and Com intervention)

EXPERIMENTAL

Participants randomized to Vita+Com will receive both Vita and Com simultaneously. They will spend 10 minutes on Vita and then 1 hour on Com per day, 2-3 days/week for 8 weeks (a total of 23.3 hours). Participants will receive weekly check-in calls from the intervention RA during the 8 weeks of intervention phase.

Behavioral: Vita+Com

Usual care

NO INTERVENTION

Participants randomized to this control condition will continue to receive their usual care, but no interventions from the study team. We will monitor changes in their activities that may affect changes in cognitive function (e.g., starting book clubs) by weekly check-in calls during the 8 weeks of intervention phase.

Interventions

VitaBEHAVIORAL

Vita is developed by this study team based on Attention Restoration Theory. The Vita intervention involves viewing 360 degree nature pictures on a virtual reality headset.

Vita (virtual reality-based cognitive restoration intervention)
ComBEHAVIORAL

Com intervention uses BrainHQ from PositScience that was developed based on the brain neuroplasticity. The com intervention involves doing game-like training on a iPad.

Com (computerized cognitive training intervention )
Vita+ComBEHAVIORAL

Vita+Com intervention is a combination of both Vita and Com interventions. Participants will be asked to complete Vita first and then Com intervention.

Vita+Com (Both Vita and Com intervention)

Eligibility Criteria

Age55 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)

You may qualify if:

  • ≥ 55 years;
  • chronic HF Stage C validated from echocardiography or comparable measure or B-type natriuretic peptide (BNP) level \> 400 pg/ml \[or equivalent NT-proBNP\] in past 3 years;
  • ability to communicate in English;
  • capacity to consent according to the Indiana University Institutional Review Board policies, or lacks capacity to consent but has the ability to provide assent from someone who can serve as LAR; and
  • Subjectively reported cognitive concern assessed by the question, "Do you have any trouble with your memory or thinking?".

You may not qualify if:

  • pre-HF (Stages A and B) or advanced HF (Stage D);
  • vision or hearing problems that can interfere with cognitive testing;
  • major neurological disorder (e.g., previously diagnosed dementia, Parkinson's disease, epilepsy, multiple sclerosis);
  • major psychiatric disease (e.g., schizophrenia, bipolar disorder);
  • life-threatening unstable illness other than HF (e.g., end-stage cancer); and
  • users of regular computerized cognitive training or participants in cognitive training trials in the past year.
  • Second, we will enroll patients only if they have MCI or normal cognition by not meeting criteria for dementia.

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Indiana University

Indianapolis, Indiana, 46202, United States

Location

MeSH Terms

Conditions

Heart FailureCognitive Dysfunction

Interventions

Vitamin AMesna

Condition Hierarchy (Ancestors)

Heart DiseasesCardiovascular DiseasesCognition DisordersNeurocognitive DisordersMental Disorders

Intervention Hierarchy (Ancestors)

RetinoidsCarotenoidsPolyenesAlkenesHydrocarbons, AcyclicHydrocarbonsOrganic ChemicalsCyclohexenesCyclohexanesCycloparaffinsHydrocarbons, AlicyclicHydrocarbons, CyclicTerpenesDiterpenesPigments, BiologicalBiological FactorsAlkanesulfonatesAlkanesulfonic AcidsAlkanesSulfhydryl CompoundsSulfur CompoundsSulfonic AcidsSulfur Acids

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
DOUBLE
Who Masked
INVESTIGATOR, OUTCOMES ASSESSOR
Masking Details
Single-blind
Purpose
SUPPORTIVE CARE
Intervention Model
FACTORIAL
Model Details: A 2 by 2 factorial design
Sponsor Type
OTHER
Responsible Party
PRINCIPAL INVESTIGATOR
PI Title
Assistant Professor

Study Record Dates

First Submitted

October 24, 2022

First Posted

November 1, 2022

Study Start

April 3, 2023

Primary Completion (Estimated)

March 31, 2027

Study Completion (Estimated)

March 31, 2027

Last Updated

March 23, 2026

Record last verified: 2026-03

Locations